over the counter glp-1 receptor agonists show promise in treating substance use disorders *Based on a 2024 survey of pharmacists who recommend branded vitamins and supplements PDB-101: Molecule of the Month:
Description
Regulatory approvals have focused on weight loss efficacy as the primary endpoint with cardiovascular benefits considered secondary outcomes
The US Department of Veterans Affairs offers comprehensive medical coverage, including prescription drug benefits to all US veterans
Parvathaneni V, Kulkarni NS, Muth A, Gupta V
GLP-1s are approved for weight loss in adults who have a body mass index of 30 or higher, and those who are overweight with a body mass index of 27 or higher with at least one weight-related health condition such as high blood pressure, high cholesterol and type 2 diabetes
Moreover, there are differences in how these products are made, and the ingredients may come from undisclosed sources
We also know that both obesity and diabetes the two conditions that GLP-1 drugs are developed to target have their own links to dementia
